MedTrace Logo

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma

NCT02385812 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-05-18

No results posted yet for this study

Summary

Asbestos defines a group of naturally occurring mineral silicate fibers which are easily inhaled, resulting in a variety of diseases of the respiratory system including lung cancer and malignant mesothelioma. Despite some advances in treatment, there has been little impact on overall survival for both lung cancer and mesothelioma in the past 20 years in great part because patients usually present with disease at an advanced and incurable stage. This study aims to develop and implement a low-dose computed tomography (LDCT) screening approach for lung cancer and mesothelioma in asbestos-exposed workers in Alberta.

Conditions

Interventions

PROCEDURE

Low-dose computed tomography Annual scan x3

Annual scan x3

PROCEDURE

Low-dose computed tomography Baseline scan only

Baseline scan only

Sponsors & Collaborators

  • Alberta Cancer Foundation

    collaborator OTHER

  • Western Canadian Mesothelioma Foundation

    collaborator UNKNOWN

  • University of Calgary

    lead OTHER

Principal Investigators

  • Alain Tremblay, MD · University of Calgary

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385812 on ClinicalTrials.gov